Notably, it did not include analyses of medullary thyroid carcinoma, nor did it investigate the effects of APOL1 on specific immune cell populations or tertiary lymphoid structures within the tumor microenvironment. Here, APOL1 is linked to medullary thyroid gland carcinoma.